http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104220451-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 2013-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104220451-B
titleOfInvention C-3 cycloalkene triterpenoids with HIV maturation inhibitory activity
abstract The invention discloses a compound with properties of medicine and biological action, its pharmaceutical composition and application method. Specifically, C-3 cycloalkene triterpenoids with unique antiviral activity are provided as HIV maturation inhibitors, said compounds are shown as compounds of formulas I, II, III and IV: wherein X can be C 4- 8 cycloalkyl, C 4-8 cycloalkenyl, C 4-9 spirocycloalkyl, C 4-9 spirocycloalkenyl, C 4-8 oxacycloalkyl, C 4-8 dioxetane Base, C 6-8 oxa-cycloalkenyl, C 6-8 dioxa-cycloalkenyl, C 6-9 oxa-spirocycloalkyl or C 6-9 oxa-spirocycloalkenyl ring. These compounds are useful in the treatment of HIV and AIDS.
priorityDate 2012-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011153319-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009100532-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009020732-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011153315-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149128218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164071188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467512244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465957054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411943602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163845556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410076711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148786826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467855103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465895687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148180809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467379259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465565738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429018453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467561786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467815067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467557978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466876446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164112466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412833781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466378064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544409

Total number of triples: 46.